EpiPen Price Hearing: House Plays Bootleg Tape Of Shkreli Event
Executive Summary
Another election year hearing on drug prices yielded more of the same discussions on price hikes and FDA's approval process.
You may also be interested in...
Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma
From Vioxx to EpiPen, industry has been called in to testify before Congress on a range of issues. But with seven big pharma leaders having accepted the Senate Finance Committee's invitation Feb. 26, the stage is set for some exceptional political theater.
Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma
From Vioxx to EpiPen, industry has been called in to testify before Congress on a range of issues. But with seven big pharma leaders having accepted the Senate Finance Committee's invitation Feb. 26, the stage is set for some exceptional political theater.
Democrat-Controlled House Will Turn Up The Volume On Drug Pricing
With US House of Representatives now controlled by Democrats, lower chamber of Congress will likely increase hearings and investigations into industry pricing practices, but any legislation will likely need to dovetail with President Trump’s agenda to advance.